DrugPatentWatch Database Preview
Patent: 6,864,264
» See Plans and Pricing
Summary for Patent: 6,864,264
| Title: | 1-adamantyl chalcones for the treatment of proliferative disorders |
| Abstract: | The present invention relates to the compounds of the general formula (I), a composition for and a method of treating breast cancer or other proliferative disorders in a subject using a compound of general formula [I], ##STR1## wherein the substituents are as defined in the specification. |
| Inventor(s): | Anderson; Gloria L. (Atlanta, GA), Kaimari; Tawfeq Abdul-Raheem (Kennesaw, GA) |
| Assignee: | |
| Application Number: | 10/224,723 |
| Patent Claims: | see list of patent claims |
Details for Patent 6,864,264
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Genentech | HERCEPTIN | trastuzumab | VIAL; INTRAVENOUS | 103792 | 001 | 1998-09-25 | Start Trial | 2039-03-29 | RX | Orphan | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patent Family for US Patent 6,864,264
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| United States of America | 2005065152 | Start Trial |
| United States of America | 2006189580 | Start Trial |
| United States of America | 2009281196 | Start Trial |
| United States of America | 2011319483 | Start Trial |
| United States of America | 7563789 | Start Trial |
| United States of America | 8013020 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
